In the demanding field of pharmaceutical synthesis, the selection of high-quality intermediates is a critical determinant of success. Methyl D-(-)-4-hydroxy-phenylglycinate, identified by CAS number 37763-23-8, stands out as a pivotal pharmaceutical intermediate, indispensable for the production of a range of vital medications. This article explores its role in synthesis and why it is a preferred choice for discerning manufacturers.
The primary function of Methyl D-(-)-4-hydroxy-phenylglycinate is as a foundational building block in the synthesis of various pharmaceutical compounds. Its molecular structure makes it particularly valuable in the creation of antibiotics, such as penicillin and cephalosporins. The chemical precision required in antibiotic production means that the purity and stereochemistry of intermediates like this one are non-negotiable. High-purity Methyl D-(-)-4-hydroxy-phenylglycinate ensures that reactions proceed smoothly, leading to the formation of the desired active pharmaceutical ingredients (APIs) with minimal by-products. For manufacturers looking to buy this compound, a guaranteed assay of 98% or higher is standard, reflecting its suitability for pharmaceutical applications.
The compound's utility extends beyond antibiotic synthesis. It plays a significant role in the synthesis of other complex organic molecules and is a key component in the development of chiral drugs. Chiral synthesis, which focuses on producing enantiomerically pure compounds, is vital for modern drug development to maximize efficacy and minimize adverse effects. Methyl D-(-)-4-hydroxy-phenylglycinate provides the necessary chiral center, enabling chemists to construct stereospecific molecules efficiently. Researchers also leverage this intermediate in pharmaceutical R&D to explore new therapeutic agents and improve existing drug formulations.
For companies seeking a reliable source for Methyl D-(-)-4-hydroxy-phenylglycinate, partnering with experienced manufacturers and suppliers is essential. Factors such as consistent quality, stable supply, and competitive pricing are key considerations when deciding where to buy. The global demand for high-quality pharmaceutical intermediates underscores the importance of a robust supply chain. We are committed to being a premier supplier, offering Methyl D-(-)-4-hydroxy-phenylglycinate that meets stringent quality standards. If your organization requires this critical intermediate for synthesis, we encourage you to contact us to discuss your needs, inquire about pricing, and secure your supply from a trusted manufacturer in China.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.